glp 1 agonist and dpp 4 inhibitor GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Insights into the Roles of
Description
JCL roundtable

According to the 2020 ADA Standards of Medical Care in Diabetes, his revascularization procedure in January 2019 is a clinical trigger to consider the addition of a glucose-lowering agent with evidence of cardiovascular benefit

Causal Inference : What If (CRC Press, 2010)

Other Healthy Eating Tips While Taking GLP-1 Medication An overall healthy lifestyle is crucial for supporting weight loss, whether or not youre taking a GLP-1 medication

What this 1-day workshop will cover: How to safely dose and monitor your patients weight loss How to recognize non responding patients and what to do next How to support your patients weight loss with GLP1s and supplements 8:00 am Weight Loss Introduction James LaValle, RPh, CCN, MT Metaflammation and understanding Mitochondrial interference Factors in metaflammation 9:00 am Insulin Resistance James LaValle, RPh, CCN, MT Cell signaling Impact of low thyroid Impact of Cortisol and stress Impact of environmental burden - Pesticides - Heavy metals - Biotoxins Key nutrients Peptides GLP-1/GIP agonists 10:30 am Managing Cortisol and Thyroid Hormone Gordon Crozier, DO Working within circadian timing Strategies for thyroid support Key nutrients, Peptides and compounded Rx 11:30 am Sex Hormones and Weight Loss Gordon Crozier, DO Testosterone Estrogens Estradiol/Estriol Progesterone balance Key nutrients 1:30 pm Exercise: Preserving Muscle During Weight Loss Cliff Edberg, RD, CPT 2:00 pm Gut-Immune-Brain Connection James LaValle, RPh, CCN, MT Impact of the Microbiome on hunger signaling and satiety Reward cascade and Hedonic Urge the dopamine connection Correcting for Gut permeability Key nutrients, peptides and compounded Rx 3:30 pm Diet: The Most Effective Diet for Lean Mass Retention and Glucose Regulation Laura LaValle, RDN, LD Impact of food sensitivities and allergies 4:30 pm Putting It All Together James LaValle, RPh, CCN, MT Options for other compounds when GLP-1 are not indicated or tolerated

Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone
